South Korea has convened an international meeting of foot-and-mouth disease (FMD) experts as concern increases over the circulation of SAT1 serotype virus in Asia, highlighting the importance of regional surveillance, laboratory diagnostics and vaccine-matching capabilities.
The meeting was organised by the Animal and Plant Quarantine Agency (APQA) in Gimcheon, Gyeongsangbuk-do, from 4 to 8 November 2026.
Participants included representatives and specialists from Mongolia, Laos, Malaysia and Bangladesh, alongside experts from the United Kingdom’s Pirbright Institute. The meeting reflects increasing concern about the movement of FMD virus variants into Asia and the need for coordinated regional preparedness.
SAT1 circulation increases regional disease-control concerns
FMD is one of the most economically consequential transboundary animal diseases, affecting cattle, buffalo, sheep, goats and pigs. The virus exists in multiple immunologically distinct serotypes, including:
-
O.
-
A.
-
C.
-
Asia 1.
-
SAT1.
-
SAT2.
-
SAT3.
The emergence or introduction of a different serotype can create difficulties for existing vaccination programmes. This is because protection against one serotype does not necessarily provide adequate protection against another.
The reported regional concern centres on SAT1 circulation in China and Mongolia and the potential implications for neighbouring livestock-producing countries. The development reinforces the importance of moving beyond generic FMD surveillance towards more detailed serotype-specific monitoring.
Pirbright Institute’s role in regional FMD preparedness
The meeting included participation from the Pirbright Institute in the UK. Pirbright is internationally recognised for its work on FMD virus research, molecular epidemiology, vaccine matching and diagnostic development.
Its FMD reference laboratory has historically supported international disease-control activities through laboratory testing and scientific cooperation. The institute’s participation is particularly relevant because vaccine selection depends on the relationship between circulating field strains and available vaccine strains.
Why vaccine matching is important
FMD vaccines are not universally interchangeable. A vaccine developed against one serotype or strain may not provide sufficient protection against a genetically or antigenically different circulating virus. Vaccine-matching studies help determine whether available vaccine strains are likely to provide adequate protection against field isolates.
These assessments are especially important when:
-
A new serotype enters a region.
-
A previously uncommon serotype begins circulating.
-
Existing vaccine programmes experience reduced effectiveness.
-
Multiple FMD lineages circulate simultaneously.
-
Countries share livestock and animal-product trade routes.
The South Korean meeting therefore has direct relevance for vaccine manufacturers and national veterinary authorities.
Key priorities emerging from regional cooperation
The discussions focused on improving the ability of participating countries to respond to FMD through:
-
Rapid virus identification: Strengthening diagnostic capabilities to identify circulating serotypes.
-
Molecular epidemiology: Improving the sharing of sequence data and epidemiological information.
-
Vaccine matching: Evaluating whether existing vaccines are suitable against circulating field strains.
-
Laboratory collaboration: Increasing technical cooperation between regional laboratories and international reference institutions.
-
Surveillance: Strengthening monitoring of livestock populations and potential cross-border transmission.
-
Preparedness: Improving national contingency planning for the introduction of new FMD serotypes.
The initiative is especially relevant to countries that rely heavily on vaccination to protect extensive cattle and buffalo populations.
Implications for India’s animal-health industry
The SAT1 development is particularly important for India. India has one of the world’s largest bovine populations and a major national FMD vaccination programme. The potential introduction of new FMD serotypes or strains creates a need for:
-
Continuous molecular surveillance.
-
Appropriate vaccine-strain selection.
-
Regional reference-laboratory collaboration.
-
Improved diagnostic coverage.
-
Serotype-specific vaccine preparedness.
-
Better epidemiological information sharing.
However, the regional meeting does not establish a confirmed SAT1 outbreak in India. It should be treated as a preparedness and surveillance signal rather than evidence of an Indian outbreak.
Commercial implications for vaccine manufacturers
The development could increase the strategic importance of serotype-specific FMD vaccines and vaccine-matching capabilities. Companies operating in this market should monitor:
-
FMD vaccine antigen composition.
-
Field efficacy against emerging strains.
-
National procurement programmes.
-
Vaccine registration and regulatory approvals.
-
Laboratory testing capabilities.
-
Regional manufacturing and supply arrangements.
For manufacturers with established FMD vaccine portfolios, the ability to rapidly adapt to changes in circulating strains is an important competitive advantage.
Outlook
South Korea’s initiative highlights the importance of regional coordination as FMD epidemiology evolves.
The key question is whether improved surveillance and vaccine-matching cooperation can translate into faster identification of new virus introductions and more effective vaccination strategies. For Asian livestock industries, the SAT1 issue reinforces the need to treat FMD as a continuously evolving transboundary disease rather than a static vaccination challenge.
